- Home
- ARQT vs TIC Comparison
ARQT vs TIC Comparison
Compare ARQT & TIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- TIC
- Stock Information
- Founded
- ARQT 2016
- TIC 1991
- Country
- ARQT United States
- TIC United States
- Employees
- ARQT N/A
- TIC N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- TIC
- Sector
- ARQT Health Care
- TIC
- Exchange
- ARQT Nasdaq
- TIC Nasdaq
- Market Cap
- ARQT 3.3B
- TIC 2.8B
- IPO Year
- ARQT 2020
- TIC N/A
- Fundamental
- Price
- ARQT $28.01
- TIC $9.21
- Analyst Decision
- ARQT Strong Buy
- TIC Buy
- Analyst Count
- ARQT 7
- TIC 3
- Target Price
- ARQT $22.17
- TIC $14.17
- AVG Volume (30 Days)
- ARQT 3.1M
- TIC 3.3M
- Earning Date
- ARQT 10-28-2025
- TIC 11-12-2025
- Dividend Yield
- ARQT N/A
- TIC N/A
- EPS Growth
- ARQT N/A
- TIC N/A
- EPS
- ARQT N/A
- TIC N/A
- Revenue
- ARQT $317,929,000.00
- TIC $1,284,070,000.00
- Revenue This Year
- ARQT $85.27
- TIC $42.61
- Revenue Next Year
- ARQT $30.70
- TIC $43.39
- P/E Ratio
- ARQT N/A
- TIC N/A
- Revenue Growth
- ARQT 129.21
- TIC 16.15
- 52 Week Low
- ARQT $9.19
- TIC $8.76
- 52 Week High
- ARQT $28.96
- TIC $14.94
- Technical
- Relative Strength Index (RSI)
- ARQT 71.06
- TIC 24.90
- Support Level
- ARQT $22.26
- TIC $10.12
- Resistance Level
- ARQT $24.39
- TIC $11.58
- Average True Range (ATR)
- ARQT 1.46
- TIC 0.59
- MACD
- ARQT 0.21
- TIC -0.24
- Stochastic Oscillator
- ARQT 85.67
- TIC 2.70
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About TIC Acuren Corporation Common Stock
Acuren Corp operates as a provider of critical asset integrity services. The company provides testing, inspection, engineering and lab testing services in different industrial markets such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company's service line includes Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, etc., Rope Access Technician Solutions (RAT), and Engineering and Lab Testing. The company has two operating and reportable segments, which are the United States, generating maximum revenue, and Canada.